Randomized phase II study of bortezomib, thalidomide, and dexamethasone with or without cyclophosphamide as induction therapy in previously untreated multiple myeloma (Q46584146)
Jump to navigation
Jump to search
scientific article published on 22 October 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase II study of bortezomib, thalidomide, and dexamethasone with or without cyclophosphamide as induction therapy in previously untreated multiple myeloma |
scientific article published on 22 October 2012 |
Statements
1 reference
Randomized phase II study of bortezomib, thalidomide, and dexamethasone with or without cyclophosphamide as induction therapy in previously untreated multiple myeloma (English)
1 reference
1 reference
Anna Dmoszynska
1 reference
Heinz Ludwig
1 reference
Luisa Viterbo
1 reference
Richard Greil
1 reference
Ivan Spicka
1 reference
Ofer Shpilberg
1 reference
Roman Hajek
1 reference
Bruno Paiva
1 reference
María-Belén Vidriales
1 reference
Graca Esteves
1 reference
Anne Marie Stoppa
1 reference
Don Robinson
1 reference
Deborah Ricci
1 reference
Andrew Cakana
1 reference
Christopher Enny
1 reference
Huaibao Feng
1 reference
Helgi van de Velde
1 reference
Jean-Luc Harousseau
1 reference
22 October 2012
1 reference
1 reference
31
1 reference
247-255
1 reference
2
1 reference
Identifiers
1 reference
1 reference